These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38327114)

  • 41. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
    Grimes P; Watson J
    Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Evaluation of a 4% Hydroquinone + 1% Retinol Treatment Regimen for Improving Melasma and Photodamage in Fitzpatrick Skin Types III-VI.
    Rendon MI; Barkovic S
    J Drugs Dermatol; 2016 Nov; 15(11):1435-1441. PubMed ID: 28095558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of topical agents in the treatment of melasma: What's evidence? A systematic review and meta-analysis.
    Chang YF; Lee TL; Oyerinde O; Desai SR; Aljabban A; Bay CP; Bain PA; Chung HJ
    J Cosmet Dermatol; 2023 Apr; 22(4):1168-1176. PubMed ID: 36566490
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized, open-label study to compare two different dosing regimens of oral tranexamic acid in treatment of moderate to severe facial melasma.
    Bhattacharjee R; Hanumanthu V; Thakur V; Bishnoi A; Vinay K; Kumar A; Parsad D; Kumaran MS
    Arch Dermatol Res; 2023 Aug; 315(6):1831-1836. PubMed ID: 36757440
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma.
    Guevara IL; Pandya AG
    Int J Dermatol; 2003 Dec; 42(12):966-72. PubMed ID: 14636195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combined use of two formulations containing diacetyl boldine, TGF-β1 biomimetic oligopeptide-68 with other hypopigmenting/exfoliating agents and sunscreen provides effective and convenient treatment for facial melasma. Either is equal to or is better than 4% hydroquinone on normal skin.
    Pratchyapurit WO
    J Cosmet Dermatol; 2016 Jun; 15(2):131-44. PubMed ID: 26833454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparing the Efficacy and Tolerability of Moderate to Severe Hyperpigmentation and Skin Unevenness.
    Callender VD; Orlinsky D; Simmons-O'Brien E; Nwade NC; Rhodes T; Byrd AS
    J Drugs Dermatol; 2024 Jan; 23(1):1260-1265. PubMed ID: 38206158
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Study of oral tranexamic acid, topical tranexamic acid, and modified Kligman's regimen in treatment of melasma.
    Sahu PJ; Singh AL; Kulkarni S; Madke B; Saoji V; Jawade S
    J Cosmet Dermatol; 2020 Jun; 19(6):1456-1462. PubMed ID: 32346962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of melasma with topical agents, peels and lasers: an evidence-based review.
    Rivas S; Pandya AG
    Am J Clin Dermatol; 2013 Oct; 14(5):359-76. PubMed ID: 23881551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma.
    Ferreira Cestari T; Hassun K; Sittart A; de Lourdes Viegas M
    J Cosmet Dermatol; 2007 Mar; 6(1):36-9. PubMed ID: 17348994
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study.
    Rendon M; Cardona LM; Bussear EW; Benitez AL; Colón LE; Johnson LA
    Cutis; 2008 Nov; 82(5):372-8. PubMed ID: 19090343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topical metformin in the treatment of melasma: A preliminary clinical trial.
    Banavase Channakeshavaiah R; Andanooru Chandrappa NK
    J Cosmet Dermatol; 2020 May; 19(5):1161-1164. PubMed ID: 31502392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful treatment of hydroquinone-resistant melasma using topical methimazole.
    Malek J; Chedraoui A; Nikolic D; Barouti N; Ghosn S; Abbas O
    Dermatol Ther; 2013; 26(1):69-72. PubMed ID: 23384022
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A pilot study using reflectance confocal microscopy (RCM) in the assessment of a novel formulation for the treatment of melasma.
    Tsilika K; Levy JL; Kang HY; Duteil L; Khemis A; Hughes R; Passeron T; Ortonne JP; Bahadoran P
    J Drugs Dermatol; 2011 Nov; 10(11):1260-4. PubMed ID: 22052305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
    Grimes PE
    Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Postinflammatory and rebound hyperpigmentation as a complication after treatment efficacy of telangiectatic melasma with 585 nanometers Q-switched Nd: YAG laser and 4% hydroquinone cream in skin phototypes III-V.
    Lueangarun S; Namboonlue C; Tempark T
    J Cosmet Dermatol; 2021 Jun; 20(6):1700-1708. PubMed ID: 33002283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Skin-lightening effects of a new face care product in patients with melasma.
    Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
    J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effective lightening of facial melasma during the summer with a dual regimen: A prospective, open-label, evaluator-blinded study.
    Kelm RC; Zahr AS; Kononov T; Ibrahim O
    J Cosmet Dermatol; 2020 Dec; 19(12):3251-3257. PubMed ID: 33058522
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of cysteamine and methimazole in treating melasma: A comparative narrative review.
    Niazi S; Gheisari M; Moravvej H; Doroodgar F; Niazi F
    J Cosmet Dermatol; 2022 Sep; 21(9):3867-3875. PubMed ID: 35751542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized, double-blind, placebo-controlled clinical trial on the efficacy and safety of 3% Rumex occidentalis cream versus 4% hydroquinone cream in the treatment of melasma among Filipinos.
    Mendoza CG; Singzon IA; Handog EB
    Int J Dermatol; 2014 Nov; 53(11):1412-6. PubMed ID: 25265986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.